Steigerwald Gordon & Koch’s Medidata Solutions, Inc. MDSO Stock Holding History

Steigerwald Gordon & Koch’s Portfolio MDSO Stock Details MDSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-5,500	Closed	-$503K	–	92
2019 Q3	$503K	Hold	5,500	–	–	0.13%	55
2019 Q2	$498K	Hold	5,500	–	–	0.13%	55
2019 Q1	$403K	Hold	5,500	–	–	0.11%	60
2018 Q4	$371K	Hold	5,500	–	–	0.11%	61
2018 Q3	$403K	Hold	5,500	–	–	0.1%	62
2018 Q2	$443K	Hold	5,500	–	–	0.12%	57
2018 Q1	$345K	Hold	5,500	–	–	0.1%	62
2017 Q4	$349K	Hold	5,500	–	–	0.1%	58
2017 Q3	$429K	Hold	5,500	–	–	0.12%	54
2017 Q2	$430K	Hold	5,500	–	–	0.12%	52
2017 Q1	$317K	Hold	5,500	–	–	0.09%	58
2016 Q4	$273K	Sell	5,500 -500	-8%	-$26K	0.09%	60
2016 Q3	$335K	Hold	6,000	–	–	0.12%	52
2016 Q2	$281K	Hold	6,000	–	–	0.1%	55
2016 Q1	$232K	Hold	6,000	–	–	0.09%	55
2015 Q4	$296K	Hold	6,000	–	–	0.12%	49
2015 Q3	$253K	Buy	+6,000	New	+$305K	0.11%	48

Other funds holding MDSO

WBC

Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return

Steigerwald Gordon & Koch's MDSO Position: Q4 2019 in Review

Steigerwald Gordon & Koch sold out of Medidata Solutions, Inc. (MDSO) in Q4 2019, closing a stake of 5,500 shares — an estimated $503K sold.

Steigerwald Gordon & Koch first reported a position in MDSO in Q3 2015 and held it in 17 quarters. The position peaked at $503K in Q3 2019. 1 fund tracked by Wall St. Rank holds MDSO as of Q4 2019.

Steigerwald Gordon & Koch reported no remaining Medidata Solutions, Inc. position as of Q4 2019 after selling out during the quarter.
Steigerwald Gordon & Koch sold 5,500 Medidata Solutions, Inc. shares in Q4 2019, an estimated $503K.
Steigerwald Gordon & Koch first reported a position in Medidata Solutions, Inc. in Q3 2015 and held it in 17 quarters.
Steigerwald Gordon & Koch's Medidata Solutions, Inc. position peaked at $503K in Q3 2019.
1 fund tracked by Wall St. Rank held Medidata Solutions, Inc. as of Q4 2019.

Based on Steigerwald Gordon & Koch's 13F filing for Q4 2019, filed 27 Jan 2020.